CEOInterviews.AI
Verified executive transcripts, quotes, and interview insights from Stoke Therapeutics leadership.
Clinical-stage company developing antisense medicines for haploinsufficient diseases such as Dravet syndrome. [BIOTECH-2026-10-04]
Search transcripts, quotes, and verified statements from every Stoke Therapeutics executive via our platform or API.